Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-09-08

Clinical Trial Update: Open-label, Multi-center Trial of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy [Phase 4]

View source ↗

Summary

Open-label Phase 4 trial of zonisamide as adjunctive therapy in uncontrolled partial epilepsy completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonisamide (zonisamide)

Snippet

Sponsor: Eisai Korea Inc. | Conditions: Epilepsy | Phase 4 | Status: COMPLETED | Results posted: 2011-09-08